Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐IL‐12/23p40 Antibodies for Maintenance of Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436690/all/Fibrinogen_concentrate_in_bleeding_patients:_Cochrane_systematic_review. Accessed 26 April 2024.
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436690/all/Fibrinogen_concentrate_in_bleeding_patients:_Cochrane_systematic_review. Accessed April 26, 2024.
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436690/all/Fibrinogen_concentrate_in_bleeding_patients:_Cochrane_systematic_review
Anti‐IL‐12/23p40 Antibodies for Maintenance of Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436690/all/Fibrinogen_concentrate_in_bleeding_patients:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
ID - 436690
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436690/all/Fibrinogen_concentrate_in_bleeding_patients:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -